A dose of private equity is apparently just what the doctor ordered. On Tuesday, UK-based PE firm Vitruvian Partners made a $ 637 million strategic investment in DeepIntent, a health care-focused demand-side platform that specializes in helping pharma brands reach patients and providers using programmatic advertising. Although Vitruvian’s portfolio includes a bunch of software, consumer tech […]
The post Health Care DSP DeepIntent Sells $ 637 Million Majority Stake To PE Firm Vitruvian Partners appeared first on AdExchanger.
More Stories
A Bon Viant; The End Of Indie Middleware
How Burger King Drank Wendy’s Milk Shake
For Advertisers, Hydration Breaks Were the Star of the World Cup